VANGL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.231600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.404600E-01
Normal-vs-Stage2
2.305400E-01
Normal-vs-Stage3
2.780600E-01
Normal-vs-Stage4
9.546400E-01
Stage1-vs-Stage2
5.964600E-01
Stage1-vs-Stage3
6.212600E-01
Stage1-vs-Stage4
6.224800E-01
Stage2-vs-Stage3
6.258600E-01
Stage2-vs-Stage4
1.413770E-01
Stage3-vs-Stage4
3.721000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.723420E-01
Normal-vs-AfricanAmerican
4.966600E-01
Normal-vs-Asian
9.883600E-01
Caucasian-vs-AfricanAmerican
7.281800E-01
Caucasian-vs-Asian
1.511390E-01
AfricanAmerican-vs-Asian
4.416600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.677200E-01
Normal-vs-Female
1.877550E-01
Male-vs-Female
7.141000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.906600E-01
Normal-vs-Age(41-60Yrs)
3.241800E-01
Normal-vs-Age(61-80Yrs)
2.215800E-01
Normal-vs-Age(81-100Yrs)
1.051520E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.399200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.728200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.101200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.084000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.144200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.825700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.175200E-01
Normal-vs-Daily Drinker
1.863050E-01
Normal-vs-Weekly Drinker
2.964600E-01
Normal-vs-Occasional Drinker
6.939200E-01
Normal-vs-Social Drinker
9.076200E-02
Non Drinker-vs-Daily Drinker
3.190800E-01
Non Drinker-vs-Weekly Drinker
8.485600E-01
Non Drinker-vs-Occasional Drinker
5.400400E-01
Non Drinker-vs-Social Drinker
4.754600E-01
Daily Drinker-vs-Weekly Drinker
4.809400E-01
Daily Drinker-vs-Occasional Drinker
1.661600E-01
Daily Drinker-vs-Social Drinker
7.909000E-01
Weekly Drinker-vs-Occasional Drinker
4.949800E-01
Weekly Drinker-vs-Social Drinker
5.930600E-01
Occasional Drinker-vs-Social Drinker
2.237400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.05790004428985E-09
Normal-vs-Grade 2
<1E-12
Normal-vs-Grade 3
2.12574402524979E-12
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.019500E-02
Grade 1-vs-Grade 3
9.376300E-03
Grade 1-vs-Grade 4
3.05790004428985E-09
Grade 2-vs-Grade 3
2.050600E-01
Grade 2-vs-Grade 4
<1E-12
Grade 3-vs-Grade 4
2.12574402524979E-12
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.133380E-01
Normal-vs-NonDiabetic
2.499800E-01
Diabetic-vs-NonDiabetic
3.130600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.274200E-01
Normal-vs-NoPancreatitis
1.849170E-01
Pancreatitis-vs-NoPancreatitis
1.078620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.711800E-01
Normal-vs-N1
1.688970E-01
N0-vs-N1
7.887600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.570200E-01
Normal-vs-TP53-NonMutant
2.011200E-01
TP53-Mutant-vs-TP53-NonMutant
8.685900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
